|
Volumn 153, Issue 3, 2013, Pages 507-508
|
Radical host-specific therapies for TB
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ALISPORIVIR;
CERAMIDE;
CYCLOPHILIN D;
DESIPRAMINE;
EARLY SECRETORY ANTIGENIC TARGET 6;
LEUKOTRIENE A4 HYDROLASE;
REACTIVE OXYGEN METABOLITE;
TUMOR NECROSIS FACTOR;
ALLELE;
ARTICLE;
BACTERIAL CLEARANCE;
BACTERIAL LOAD;
CELL DEATH;
CYTOKINE PRODUCTION;
DISEASE COURSE;
GENE TARGETING;
GENOTYPE;
GRANULOCYTE;
HOST RANGE;
HUMAN;
HUMAN IMMUNODEFICIENCY VIRUS INFECTION;
MACROPHAGE;
MIXED INFECTION;
MYCOBACTERIUM TUBERCULOSIS;
NECROPTOSIS;
NONHUMAN;
PHAGOSOME;
PHENOTYPE;
PRIORITY JOURNAL;
TUBERCULOUS MENINGITIS;
BACTERIA (MICROORGANISMS);
|
EID: 84876925928
PISSN: 00928674
EISSN: 10974172
Source Type: Journal
DOI: 10.1016/j.cell.2013.04.019 Document Type: Short Survey |
Times cited : (5)
|
References (10)
|